← 產業報告目錄

eConsent In Healthcare Market Size, Share & Trends Analysis Report by Platform (Cloud-based, Web-based), By Enrollment Type (On-Site, Remote), By Form Type (General Consent, General Consent With Specific Denial(S), General Denial With Specific Consent(S) And General Denial), Region And Segment Forecasts, 2025-2034

出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-20頁數 180報告編號 INSIGHTACE-78055a1159

授權報價

Single User PDF$4,500 USD
Global Site License PDF$9,500 USD
洽詢購買 申請 Sample

報告摘要

In 2024, the eConsent In Healthcare Market worldwide was assessed at USD 534.3 million. Analysts project it will progress to USD 1,211.8 million by 2034, at a CAGR of 9.3% spanning 2025 to 2034. At its core, eConsent In Healthcare pertains to a critical procedure in clinical trials involving communication, discussion, and agreement between participants and researchers. Stakeholders across the healthcare landscape are risingly turning to these solutions to meet contemporary demands. The market's upward path is bolstered by rising healthcare spending, technological evolution, and the rising focus on personalized and precision-based approaches in healthcare. From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities. Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region set to deliver the strongest growth trajectory through the forecast period, bolstered by demographic shifts and policy support. Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players. Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global eConsent in Healthcare Market Snapshot Chapter 4. Global eConsent in Healthcare Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. Competitive Landscape & Market Share Analysis 4.8. Impact of Covid-19 Analysis Chapter 5. Market Segmentation 1: by Platform Estimates & Trend Analysis 5.1. by Platform & Market Share, 2024 & 2034 5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Platform: 5.2.1. Cloud-based 5.2.2. Web-based Chapter 6. Market Segmentation 2: by Enrollment Type Estimates & Trend Analysis 6.1. by Enrollment Type & Market Share, 2024 & 2034 6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Enrollment Type: 6.2.1. On-site 6.2.2. Remote Chapter 7. Market Segmentation 3: by Form Type Estimates & Trend Analysis 7.1. by Form Type & Market Share, 2024 & 2034 7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Form Type: 7.2.1. General Consent 7.2.2. General Consent with Specific Denial(s) 7.2.3. General Denial with Specific Consent(s) 7.2.4. General Denial Chapter 8. eConsent in Healthcare Market Segmentation 4: Regional Estimates & Trend Analysis 8.1. North America 8.1.1. North America eConsent in Healthcare Market Revenue (US$ Million) Estimates and Forecasts by Platform, 2021-2034 8.1.2. North America eConsent in Healthcare Market Revenue (US$ Million) Estimates and Forecasts by Enrollment Type, 2021-2034 8.1.3. North America eConsent in Healthcare Market Revenue (US$ Million) Estimates and Forecasts by Form Type, 2021-2034 8.1.4. North America eConsent in Healthcare Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 8.2. Europe 8.2.1. Europe eConsent in Healthcare Market Revenue (US$ Million) Estimates and Forecasts by Platform, 2021-2034 8.2.2. Europe eConsent in Healthcare Market Revenue (US$ Million) Estimates and Forecasts by Enrollment Type, 2021-2034 8.2.3. Europe eConsent in Healthcare Market Revenue (US$ Million) Estimates and Forecasts by Form Type, 2021-2034 8.2.4. Europe eConsent in Healthcare Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 8.3. Asia Pacific 8.3.1. Asia Pacific eConsent in Healthcare Market Revenue (US$ Million) Estimates and Forecasts by Platform, 2021-2034 8.3.2. Asia Pacific eConsent in Healthcare Market Revenue (US$ Million) Estimates and Forecasts by Enrollment Type, 2021-2034 8.3.3. Asia-Pacific eConsent in Healthcare Market Revenue (US$ Million) Estimates and Forecasts by Form Type, 2021-2034 8.3.4. Asia Pacific eConsent in Healthcare Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 8.4. Latin America 8.4.1. Latin America eConsent in Healthcare Market Revenue (US$ Million) Estimates and Forecasts by Platform, 2021-2034 8.4.2. Latin America eConsent in Healthcare Market Revenue (US$ Million) Estimates and Forecasts by Enrollment Type, 2021-2034 8.4.3. Latin America eConsent in Healthcare Market Revenue (US$ Million) Estimates and Forecasts by Form Type, 2021-2034 8.4.4. Latin America eConsent in Healthcare Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 8.5. Middle East & Africa 8.5.1. Middle East & Africa eConsent in Healthcare Market Revenue (US$ Million) Estimates and Forecasts by Platform, 2021-2034 8.5.2. Middle East & Africa eConsent in Healthcare Market Revenue (US$ Million) Estimates and Forecasts by Enrollment Type, 2021-2034 8.5.3. Middle East & Africa eConsent in Healthcare Market Revenue (US$ Million) Estimates and Forecasts by Form Type, 2021-2034 8.5.4. Middle East & Africa eConsent in Healthcare Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 Chapter 9. Competitive Landscape 9.1. Major Mergers and Acquisitions/Strategic Alliances 9.2. Company Profiles 9.2.1. Advarra 9.2.2. OpenClinica, LLC 9.2.3. 5thPort, LLC 9.2.4. Calysta EMR 9.2.5. Castor 9.2.6. Citadel Group 9.2.7. Climedo Health GmbH 9.2.8. ClinConsent, LLC. 9.2.9. Clinical ink 9.2.10.Clinical Trials Arena 9.2.11.ClinOne 9.2.12.Cloudbyz 9.2.13.Concentric Health Ltd 9.2.14.Crucial Data Solutions 9.2.15.Curebase 9.2.16.Dacima Software Inc ( EvidentIQ Group) 9.2.17.Datacubed Health 9.2.18.DataRiver S.r.l. 9.2.19.Definitive Healthcare, LLC 9.2.20.Delve Health 9.2.21.EClinCloud (Shenzhen) Technology Co., Ltd 9.2.22.eClinicalHealth 9.2.23.Eclipse 9.2.24.EvidentIQ Group GmbH 9.2.25.Florence Healthcare 9.2.26.ICON plc 9.2.27.Interlace Health 9.2.28.IQVIA 9.2.29.Jeeva Clinical Trials Inc. 9.2.30.Kayentis 9.2.31.Magentus 9.2.32.Medable Inc. 9.2.33.Medidata 9.2.34.Mednet 9.2.35.Medrio 9.2.36.Milo Healthcare 9.2.37.Obvio Health USA, Inc. 9.2.38.Octalsoft (Glorant, LLC USA) 9.2.39.RealTime Software Solutions, LLC 9.2.40.Signant Health 9.2.41.Sitero 9.2.42.StudyKIK (Syneos Health) 9.2.43.Suvoda LLC 9.2.44.Thieme Compliance GmbH 9.2.45.THREAD 9.2.46.Veeva Systems 9.2.47.Wellbeing Software 9.2.48.YonaLink 9.2.49.Y-Prime, LLC 9.2.50.Сlinсapture

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們